Flesh Trade: Why not let people sell their organs? We already pay healthy people to risk their health in safety trials of new drugs (
Freakonomics, Stephen J. Dubner and Steven D. Levitt, July 9). The risks in these trials can be harder to control than the risks in well-studied transplant procedures. We also pay people to risk their health in other
(
Read more... )
Comments 1
Reply
Leave a comment